The company
Penumbra, Inc.
PEN · NYSE
PEN stood above a rising 150-day average in 27 of the last 52 weekly readings, and has been out of that trend for the last 20 weeks. It is 0.2% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 20
- Industry in uptrend
- 29% -4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $12.1M
- Officials’ trades on record
- 8
- Institutions holding
- 416 (-29)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
8 disclosed lines: House 5, Senate 0, executive 3; 3 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 23 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 17 Apr 2026filed 1 Jul 2026 |
| Lisa C. McClain House: U.S. House ClerkMI09 | soldspouse | $1k–$15k | 10 Jul 2025filed 13 Aug 2025 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 28 Nov 2017filed 6 Dec 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $15k–$50k | 13 Jan 2017filed 24 Jan 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $15k–$50k | 13 Dec 2016filed 20 Dec 2016 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $15k–$50k | 22 Nov 2016filed 6 Dec 2016 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Harpreet GrewalDirector | sold | 100at $328.22 | 2 Apr 2026filed 6 Apr 2026 |
| Maggie YuenChief Financial Officer | sold | 2,432at $342.30 | 2 Mar 2026filed 4 Mar 2026 |
| Harpreet GrewalDirector | sold | 186at $312.64 | 6 Jan 2026filed 8 Jan 2026 |
| Thomas WilderDirector | sold | 186at $310.72 | 2 Jan 2026filed 6 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 4,297,555$1.4B | -32,901−0.8% |
| HBK INVESTMENTS L Padded · filed 14 Aug 2026 | 1,838,508$580.5M | +204,247+12.5% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,709,877$539.9M | +15,389+0.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,667,276$526.4M | +12,799+0.8% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 1,243,258$392.6M | +57,447+4.8% |
| ExodusPoint Capital Management, LPadded · filed 14 Aug 2026 | 1,090,430$344.3M | +625,215+134.4% |
| Balyasny Asset Management L.P.added · filed 14 Aug 2026 | 1,090,163$344.2M | +328,067+43.0% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 1,071,454$338.6M | +1,071,454 |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 847,104$267.5M | +126,529+17.6% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIPadded · filed 13 Aug 2026 | 834,903$263.6M | +434,743+108.6% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.